3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Head & Neck
2
Conditions
Head and Neck Neoplasms
2
Breast Neoplasms
2
Vomiting
1
Shoulder Pain
1
Postoperative Nausea and Vomiting
1
Neoplasms
1
Muscular Atrophy
1
Lymphedema
1
Gastrointestinal Neoplasms
1
Edema
1
Colorectal Neoplasms
1
Interventions
Cisplatin
141
Radiotherapy
115
Cetuximab
95
Docetaxel
69
Radiotherapy, Intensity-Modulated
55
Carboplatin
47
pembrolizumab
46
Surveys and Questionnaires
46
Paclitaxel
41
Fluorouracil
39
Radiation
29
Blood Specimen Collection
27
Drug Therapy
26
Erlotinib Hydrochloride
23
Nivolumab
21
Surgical Procedures, Operative
17
Standard of Care
16
Magnetic Resonance Spectroscopy
16
Radiosurgery
14
Pemetrexed
14
Gemcitabine
14
Everolimus
13
Celecoxib
13
durvalumab
12
Low-Level Light Therapy
12
Immunohistochemistry
12
Cyclophosphamide
12
Capecitabine
12
Amifostine
12
Chemoradiotherapy
11
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Head and Neck Neoplasms
×
Electric Stimulation
×
Clear all
NCT07074392
2025-08-19
SpARES
McMaster University
Phase NA
Not yet recruiting
38 enrolled
NCT02268344
2020-05-07
ESSAN
University of Alberta
Phase NA
Completed
68 enrolled